Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — Q1 2016 Earnings Presentation

9 slides from Novonesis A/s Class B's earnings presentation, Apr 20, 2016

  1. Slide 1: Conference call Q1 2016

    Conference call Q1 2016 ​April 20, 2016

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements ​This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "be

  3. Slide 3: Q1 2016 Summary

    Q1 2016 Summary ​Sales growth as expected in first quarter; Sales and organic growth Q1 2014 – Q1 2016 profitability stays healthy 11% DKKm • 2% organic sales growth and 1% growth in DKK driven by 12% 4,000 solid growth in Household Care and Technical & Pharma 10% 8% 8% 3,500 • Agriculture came in r

  4. Slide 4: New organizational structure in place

    New organizational structure in place CEO & President Peder Holk Nielsen Research, Corporate Agriculture & Innovation & Supply HHC & Technical Food & Beverages Functions Bioenergy COO & EVP EVP Anders Lund EVP Andrew Fordyce CFO & EVP EVP Tina S. Fanø Thomas Videbæk Benny D. Loft 4

  5. Slide 5: Household Care & Technical

    Household Care & Technical Organic growth / DKK growth +5% / +4% Household Care • Satisfactory start to the year driven by strong growth in the emerging markets, except for Latin America. Early signs of recovery in the North American detergent market, while Europe is slightly up • Demand for premium

  6. Slide 6: Agriculture & Bioenergy

    Agriculture & Bioenergy Organic growth / DKK growth ​Bioenergy • Compared to Q1 2015 sales is down as expected due to trade- -6% / -5% -8% / -10% down as customers continue to focus on reducing cost base and optimizing production economy in a low-margin environment • Penetration of Avantec Amp® and

  7. Slide 7: Food & Beverages

    Food & Beverages Organic growth / DKK growth ​Baking +2% / +1% • Continued growth, although at a lower pace than last year and mainly from emerging markets ​Starch • Slightly positive; Chinese market is now more stable ​Food & Nutrition 926 921 • Good development in enzymes for low lactose milk but

  8. Slide 8: Research & Innovation update

    Research & Innovation update Agriculture Food & Beverages Alterion® – new probiotic for poultry ​Saphera® – new lactase enzyme • Promotes more sustainable livestock farming • Achieves better control of lactose elimination dairy • Improves feed conversion and gut health • Better stability of sweetnes

  9. Slide 9: Financial performance & outlook

    Financial performance & outlook ​Q1 2016: Profitability in line with expectations • Adjusting for the net one-time impact from the reorganization, Key Realized 2016 outlook EBIT grew by ~4% and EBIT margin expanded to ~28% April 20 financials Q1 2016 • Gross margin slightly down due to restructuring

Novozymes — Q1 2016 Earnings Presentation on 6ix